References
- Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am 1991; 75: 495–513.
- Capri S. A framework for an economic appraisal of single-dose drug. In: Neu HC, Williams JD, eds. New Trends in Urinary Tract Infections. Basel: Karger, 1989: 110–115.
- Bailey RR. Cost-benefit considerations in the manage-ment of uncomplicated urinary tract infections in sexually active women. NZ Med J 1987; 100: 680–683.
- Carlson KJ. Cost-effectiveness analysis of single-dose therapy of urinary tract infection compared to conventional treatment. Eur Urol 1987; 135: 45–47.